Kutanios
The coming revolution in skincare: LIPOXERASE™
London, United Kingdom · Founded 2017
- Headquarters
- London
- Employees
- 1–10
- Founded
- 2017
- Website
- kutanios.com
- Last Round
- SeedAug 2021
- Rounds
- 1
About
Kutanios is a London-based biotechnology startup developing novel lipid-based molecules to detoxify skin and protect against aging, cancer, acne, and environmental damage. The company's lead technology, LIPOXERASE, transfers the beneficial detoxification properties of HDL particles (good cholesterol) into topical skincare formulations, targeting the toxic lipid peroxide accumulation that drives skin aging and disorders. Founded in 2017 by Dr. Irina Miller and Norman Miller, Kutanios is an alumnus of the SOSV IndieBio NY accelerator program.
Summary
Kutanios is a Biotech company based in London, United Kingdom, founded in 2017. Its most recent funding was a Seed round in Aug 2021. Investors include SOSV.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2021
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.